Get the Stockscreener App
7.69
1.45%
0.11
After Hours:
7.73
0.04
+0.52%
Gyre Therapeutics Inc stock is traded at $7.69, with a volume of 55,662.
It is up +1.45% in the last 24 hours and up +11.13% over the past month.
Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.
See More
Previous Close:
$7.58
Open:
$7.66
24h Volume:
55,662
Relative Volume:
0.42
Market Cap:
$740.65M
Revenue:
$106.66M
Net Income/Loss:
$15.16M
P/E Ratio:
82.25
EPS:
0.0935
Net Cash Flow:
$6.37M
1W Performance:
-0.65%
1M Performance:
+11.13%
6M Performance:
-30.85%
1Y Performance:
-34.94%
1-Day Range:
$7.6591
$7.91
1-Week Range:
$7.02
$8.12
52-Week Range:
$6.11
$19.00
Gyre Therapeutics Inc Stock (GYRE) Company Profile
Name
Gyre Therapeutics Inc
Sector
Industry
Phone
(619) 949-3681
Address
12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO
Compare GYRE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GYRE
Gyre Therapeutics Inc
|
7.69 | 688.47M | 106.66M | 15.16M | 6.37M | 0.0935 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-26-25 | Initiated | H.C. Wainwright | Buy |
| Mar-11-25 | Initiated | Noble Capital Markets | Outperform |
| Apr-29-21 | Resumed | Stephens | Overweight |
| Feb-10-21 | Initiated | Piper Sandler | Overweight |
| May-21-20 | Initiated | Raymond James | Outperform |
| Jan-04-19 | Initiated | Oppenheimer | Outperform |
| Feb-12-18 | Reiterated | B. Riley FBR, Inc. | Buy |
| Feb-09-18 | Reiterated | Chardan Capital Markets | Buy |
| Dec-08-17 | Initiated | B. Riley FBR, Inc. | Buy |
| Jun-12-17 | Initiated | Chardan Capital Markets | Buy |
| Jun-06-17 | Initiated | Ladenburg Thalmann | Buy |
| Jun-30-16 | Initiated | Rodman & Renshaw | Buy |
View All
Gyre Therapeutics Inc Stock (GYRE) Latest News
Price action breakdown for Gyre Therapeutics Inc.Options Play & High Accuracy Swing Trade Signals - Newser
Live market analysis of Gyre Therapeutics Inc.July 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - Newser
Will Gyre Therapeutics Inc. see short term momentum2025 Market Outlook & Smart Money Movement Tracker - Newser
Will a bounce in Gyre Therapeutics Inc. offer an exit2025 Market Outlook & Proven Capital Preservation Tips - Newser
Full technical analysis of Gyre Therapeutics Inc. stockJuly 2025 Decliners & Expert Verified Stock Movement Alerts - Newser
Published on: 2025-09-06 21:07:55 - Newser
Gyre Therapeutics Inc.’s volatility index tracking explainedDividend Hike & Expert Approved Momentum Trade Ideas - Newser
What Fibonacci levels say about Gyre Therapeutics Inc. rebound2025 Sector Review & High Yield Stock Recommendations - Newser
Can a trend reversal in Gyre Therapeutics Inc. lead to recoveryOil Prices & Short-Term High Return Ideas - Newser
MACD Cross Could Confirm Trend in Gyre Therapeutics Inc.Market Risk Analysis & Safe Swing Trade Setups - beatles.ru
Is Gyre Therapeutics Inc. meeting your algorithmic filter criteriaMarket Performance Report & Advanced Technical Signal Analysis - Newser
Is Gyre Therapeutics Inc. benefiting from interest rate changesJuly 2025 Technicals & Free Technical Pattern Based Buy Signals - خودرو بانک
Is Gyre Therapeutics Inc. a potential multi baggerJuly 2025 Chart Watch & Safe Entry Momentum Stock Tips - خودرو بانک
Gyre Therapeutics’ Strategic Position in the Fibrosis Therapeutics Market - AInvest
Gyre Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference - The Manila Times
Published on: 2025-09-05 14:39:34 - Newser
Can Gyre Therapeutics Inc. reach all time highs this year2025 Market WrapUp & Stepwise Trade Execution Plans - خودرو بانک
Gyre Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 PostEarnings & Weekly Top Gainers Trade List - Newser
How to interpret RSI for Gyre Therapeutics Inc. stockQuarterly Investment Review & Free Reliable Trade Execution Plans - Newser
RSI + MACD Show Convergence for Gyre Therapeutics Inc.2025 Price Momentum & Daily Market Momentum Tracking - Newser
News impact scoring models applied to Gyre Therapeutics Inc.Weekly Profit Report & Daily Volume Surge Trade Alerts - Newser
What is the next catalyst for Gyre Therapeutics Inc.2025 Dividend Review & Precise Swing Trade Alerts - خودرو بانک
Technical analysis overview for Gyre Therapeutics Inc. stockWeekly Market Summary & Fast Entry and Exit Trade Plans - Newser
Gyre Therapeutics Inc. stock trendline breakdownWeekly Earnings Recap & Safe Entry Point Identification - Newser
What is Gyre Therapeutics Inc. s revenue forecastQuarterly Risk Review & Fast Moving Market Watchlists - خودرو بانک
Published on: 2025-09-03 09:00:46 - Newser
Can Gyre Therapeutics Inc. stock outperform in a bear marketTrade Exit Summary & Growth Oriented Trading Recommendations - خودرو بانک
Gyre Therapeutics Inc. stock momentum explainedQuarterly Profit Review & Community Consensus Trade Signals - Newser
Custom watchlist performance reports with Gyre Therapeutics Inc.2025 Earnings Surprises & Weekly Return Optimization Alerts - Newser
Predicting Gyre Therapeutics Inc. trend using moving averagesTrade Volume Summary & Stock Market Timing Techniques - Newser
Real time scanner hits for Gyre Therapeutics Inc. explained2025 Sector Review & Daily Chart Pattern Signal Reports - Newser
Forecasting Gyre Therapeutics Inc. price range with options dataWeekly Investment Report & Verified Stock Trade Ideas - Newser
Will Gyre Therapeutics Inc. benefit from sector rotationJuly 2025 Update & Weekly High Momentum Picks - خودرو بانک
Is Gyre Therapeutics Inc. a defensive stock2025 Dividend Review & AI Based Trade Execution Alerts - خودرو بانک
Published on: 2025-09-02 13:14:36 - Newser
Sell Signal: Can Gyre Therapeutics Inc. reach all time highs this year - خودرو بانک
What is Gyre Therapeutics Inc. s P E ratio telling usWeekly Investment Summary & Long-Term Safe Investment Ideas - خودرو بانک
Can Gyre Therapeutics Inc. recover in the next quarterWeekly Risk Summary & Safe Capital Growth Stock Tips - Newser
Gyre therapeutics president Ma Songjiang sells $46,360 in stock - MSN
Gyre Therapeutics Inc Stock (GYRE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):